Federated Hermes (NYSE:FHI – Get Free Report) is scheduled to issue its quarterly earnings data after the market closes on Thursday, October 24th. Analysts expect the company to announce earnings of $0.89 per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.
Federated Hermes (NYSE:FHI – Get Free Report) last released its quarterly earnings data on Thursday, July 25th. The company reported $0.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.07. The business had revenue of $402.60 million for the quarter, compared to analysts’ expectations of $400.35 million. Federated Hermes had a return on equity of 28.60% and a net margin of 15.90%. Federated Hermes’s quarterly revenue was down 7.1% on a year-over-year basis. During the same period in the previous year, the business posted $0.81 earnings per share. On average, analysts expect Federated Hermes to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.
Federated Hermes Stock Down 1.5 %
Shares of FHI stock opened at $38.19 on Wednesday. Federated Hermes has a one year low of $30.23 and a one year high of $39.03. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.75 and a quick ratio of 2.09. The stock has a fifty day moving average price of $35.53 and a 200 day moving average price of $34.15. The stock has a market cap of $3.21 billion, a P/E ratio of 10.85, a price-to-earnings-growth ratio of 1.41 and a beta of 1.16.
Federated Hermes Increases Dividend
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on FHI shares. JPMorgan Chase & Co. increased their price target on shares of Federated Hermes from $46.00 to $47.00 and gave the stock an “overweight” rating in a research report on Thursday, July 11th. Royal Bank of Canada raised their target price on Federated Hermes from $35.00 to $36.00 and gave the stock a “sector perform” rating in a research report on Friday, October 11th. Evercore ISI increased their price objective on Federated Hermes from $36.00 to $38.00 and gave the stock an “outperform” rating in a research note on Friday, October 4th. UBS Group boosted their target price on shares of Federated Hermes from $36.00 to $40.00 and gave the company a “neutral” rating in a research note on Tuesday. Finally, StockNews.com raised shares of Federated Hermes from a “hold” rating to a “buy” rating in a research note on Friday, October 4th. Three analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat, Federated Hermes presently has an average rating of “Moderate Buy” and a consensus target price of $38.80.
View Our Latest Research Report on Federated Hermes
Insider Buying and Selling at Federated Hermes
In other news, VP John B. Fisher sold 79,830 shares of the company’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $32.71, for a total transaction of $2,611,239.30. Following the transaction, the vice president now directly owns 442,570 shares in the company, valued at approximately $14,476,464.70. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 3.70% of the company’s stock.
Federated Hermes Company Profile
Federated Hermes, Inc is a publicly owned investment manager. Through its subsidiaries, the firm provides its services to individuals, including high net worth individuals, banking or thrift institutions, investment companies, pension and profit sharing plans, pooled investment vehicles, charitable organizations, state or municipal government entities, and registered investment advisors.
Further Reading
- Five stocks we like better than Federated Hermes
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- Top Biotech Stocks: Exploring Innovation Opportunities
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- When to Sell a Stock for Profit or Loss
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for Federated Hermes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Federated Hermes and related companies with MarketBeat.com's FREE daily email newsletter.